FDA Will Limit Covid-19 Vaccines To Those Over 65 Or At High Risk

In this week’s edition of InnovationRx, we look at the FDA’s new COVID-19 vaccine rules, Novartis’s acquisition strategy, Medtronic’s diabetes spinoff, Regeneron’s purchase of 23AndMe, and more. To get it in your inbox, subscribe here.

On Tuesday, the FDA announced that it’s adopting a new regulatory framework for COVID-19 vaccines. Under this guidance, published in the New England Journal of Medicine, recommendations for booster shots will be limited to those 65 and older…